CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 10-K/A Report 10-K/A
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 1 of 21 · 404 filings